Editorial by Prof Manolis Tsiknakis, Coordinator of ProCAncer-I project The ProCAncer-I consortium welcomes you to our first newsletter! We are very happy that our project ProCAncer-I on dealing with prostate cancer was funded by the EU and that through its successful...
Newsletter #1
MRI based Artificial Intelligence tools will improve the management of patients with prostate cancer
Βy Prof. Daniele Regge [Chief of the Radiology Unit, Candiolo Cancer Institute, Torino-Italy] and Simone Mazzetti [Candiolo Cancer Institute, Torino-Italy] Prostate cancer is the most frequently diagnosed tumour in Europe with one new cancer detected every...
The major challenge of a common anonymization strategy
Βy Prof Kostas Marias [Foundation for Research and Technology - Hellas (FORTH)], Ioannis Karatzanis [Foundation for Research and Technology - Hellas (FORTH)] and Katerina Nikiforaki [Foundation for Research and Technology - Hellas (FORTH)] Anonymization is an...
Interview with Dr. Nickolas Papanickolaou (Scientific Coordinator of the project) on the vision of the project
Βy Nickolas Papanikolaou [Principal Investigator in Oncologic Imaging at the Fundação Champalimaud] Why did you select prostate cancer as the center of your research? What kind of clinical unmet needs will be addressed in ProCancer-I? Prostate cancer is among the most...
Legal and Ethical Aspects of ProCAncer-I: The Anonymisation of Personal Data
By the legal team of ProCAncer-I, The University of Vienna Department of Innovation and Digitalisation in Law (UNIVIE) Given the innovative nature of the technology being developed in the ProCAncer-I project, complex legal questions have arisen concerning the...
Presentation of partner Radboud UMC – Major Clinical partner of the project
By the Radboud UMC Radboudumc is one of the leading centres for prostate cancer imaging worldwide. Within the ProCAncer-I project, two groups of the Department of Imaging of Radboudumc are represented. The Diagnostic Image Analysis Group (DIAG), under the...
Presentation of partner UNIVIE – Legal partner of the project
By the University of Vienna – Department of Innovation and Digitalisation in Law (UNIVIE) The University of Vienna is the oldest University in the German-speaking world, and the Department of Innovation and Digitalisation in Law is the newest addition to the...
Newsletter #1 Contents
Highlights

ProCAncer-I in the IEEE-MeMeA Conference in Taormina
Jun 17, 2022
We are looking forward to participating it the upcoming IEEE-MeMeA Conference in Taormina! The 17th edition of IEEE International Symposium on Medical Measurements and Applications will take place in Giardini Naxos, Taormina in the metropolitan area of Messina,...

1st ProCAncer-I Project Dissemination Event in Vienna
May 31, 2022
We are really happy to announce that we will be present at the ECR Congress in Vienna on 13 - 17 of July 2022. During the congress, a special Session will take place on the 15th of July, presenting and discussing on the ProCAncer-I project with the title: Building...

Data sharing for a good cause – How the Data Governance Act (DGA) will help ProCAncer- I
May 28, 2022
The European Union is actively working on improving the digital environment for the benefit of all Europeans. Professor Tsiknakis took part in a recent feature in the EU Council site on how the EU protects users online, ensures cybersecurity and facilitates the...

Use Cases mapped along the prostate cancer management continuum
Apr 6, 2022
Nowadays, prostate cancer is highly curable if detected in its early stages. Indeed, when organ-confined at diagnosis, the five-year survival rate of prostate cancer is close to 100%. Unfortunately, current prostate cancer diagnostic pipeline has several limitations. Prostate specific antigen (PSA) has a low sensitivity and specificity.
👏New paper published! 👏
How the ability of radiomic features to discriminate different image textures varies with the volume of the analyzed region.
➡️ https://www.mdpi.com/2076-3417/12/11/5465
.
.
.
#cancer #reasearch #health_data #data_imaging #artificialintelligence #ai #health #data
Nowadays, #prostatecancer diagnosis is not ideal. It usually requires a painful procedure and is not always exempted from certain side effects. So, is it possible to detect this pathology in a non-invasive way?
https://bit.ly/3mtX8ft
#AI
👏Congrats!👏
New conference presentation "On the Effectiveness of 3D Vision Transformers for the Prediction of Prostate Cancer Aggressiveness" at the workshop "Medical Transformers" afferent to the #ICIAP2021
#H2020 #EU_HEALTH #cancer #reasearch #health_data #data_imaging #ai